Maman Biomedical
Needle‑free microneedle patches and biosensors for safer, simpler hormone therapy.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Needle‑free microneedle patches and biosensors for safer, simpler hormone therapy.
FertilityEndocrinology
Technology Platform
Dissolving microneedle patches for sustained, needle‑free hormone delivery combined with a wearable biosensor for real‑time monitoring.
Opportunities
Expansion of needle‑free delivery to broader endocrine therapies and licensing of the microneedle platform to pharma partners.
Risk Factors
Regulatory approval for combination device‑drug products and scaling manufacturing of high‑precision microneedle patches.
Competitive Landscape
Competes with companies like Zosano, Valeritas, and 3M’s microneedle initiatives; differentiation lies in integrated biosensing and focus on hormone therapy.